[1]
R. Nawale, S. Pol, P. Puranik, A. Daud, and V. Rajkondawar, “ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DABIGATRAN ETEXILATE RELATED SUBSTANCE IN PHARMACEUTICAL DOSAGE FORM BY REVERSE‑PHASE – HIGH‑PERFORMANCE LIQUID CHROMATOGRAPHY”, Asian J Pharm Clin Res, vol. 11, no. 10, pp. 357–364, Oct. 2018.